logo


Obagi Medical Products Releases Results of a Clinical Trial Showing Optimized Patient Outcomes When Condition & Enhance System is Used in Combination with Botulinum Toxin Type A
Thursday, July 30, 2009 7:05 AM


Clinical study reveals patients using Condition & Enhance™ in conjunction with BOTOX® treatments achieved an 86 percent overall improvement in facial appearance vs. 8 percent who used a standard skincare regimen with BOTOX®

Obagi Medical Products, Inc. (Nasdaq: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced positive study results at the American Academy of Dermatology’s (AAD) Summer Academy Meeting in Boston, Mass., showing that the use of its Condition & Enhance System, when combined with Botulinum Toxin Type A treatments (BOTOX®), provides greater improvement in overall facial appearance, as well as increased patient satisfaction, vs. BOTOX treatments with placebo.

“I regularly have patients come in and ask for BOTOX or other aesthetic procedures, but they have aged skin that doesn’t always look markedly improved with injectables alone. This data clearly highlights the fact that by adding Condition & Enhance to an injectable patients’ treatment regimen, you are addressing all facets of aging skin for optimal results which ultimately improves patient outcome and satisfaction, even in patients who have previously had BOTOX,” said Joel Schlessinger, MD, board certified dermatologist from Omaha, Neb., director of Skin Specialists P.C., and lead investigator of the study. “And perhaps even more importantly, 100% of study participants using the Condition & Enhance System wished to continue treatment after the close of the study.”

At the conclusion of the study, physician ratings of overall improvement in facial appearance were significantly greater with the Condition & Enhance System + BOTOX as compared to BOTOX with a standard skincare regimen. Also, it was found that 86 percent of Condition & Enhance + BOTOX patients achieved an overall improvement in facial appearance vs. 8 percent using BOTOX with a standard skincare regimen by the end of the trial. In addition, statistically significant benefits were seen in evenness of facial skin color tone and facial skin texture, as well as improved levels of skin laxity and fine lines and wrinkles.

Similarly, the Condition & Enhance System was clinically proven to increase patient satisfaction: 82 percent of study participants had peers notice a positive change in overall facial appearance, as compared to 16 percent of study participants in the standard skincare group.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia